CAR T-Cell Therapy for Cancer: Latest Updates and Challenges, with a Focus on B-Lymphoid Malignancies and Selected Solid Tumours

Although exponential progress in treating advanced malignancy has been made in the modern era with immune checkpoint blockade, survival outcomes remain suboptimal. Cellular immunotherapy, such as chimeric antigen receptor T cells, has the potential to improve this. CAR T cells combine the antigen sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hiu Kwan Carolyn, Wang, Bo, Tan, Hui Xian, Sarwar, Muhammad Adeel, Baraka, Bahaaeldin, Shafiq, Tahir, Rao, Ankit R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296619/
https://www.ncbi.nlm.nih.gov/pubmed/37371056
http://dx.doi.org/10.3390/cells12121586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296619/
https://www.ncbi.nlm.nih.gov/pubmed/37371056
http://dx.doi.org/10.3390/cells12121586

Ejemplares similares